UNSPSC 51192101: Colchicine/probenecid

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class MS400. This VA Drug Class (MS400) classifies this compound as belonging to the group ANTIGOUT AGENTS.

UNSPSC 51192101 Colchicine/probenecid is a Commodity code that nominally covers a specific pharmaceutical combination product, yet recent state and local procurement activity under this code shows no alignment with that narrow scope. The three most recent opportunities posted under this code span athletic training services for public safety departments, medical aid supplies for fire rescue operations, and a request for information about direct-to-manufacturer prescription programs — none of which involve colchicine/probenecid or pharmaceutical procurement in the conventional sense. This mismatch suggests either persistent miscoding at the issuing-body level or that the code has been repurposed in state and local systems to flag miscellaneous health and medical procurement beyond its nominal taxonomy definition.

The issuing bodies posting under this code are city-level procurement offices: the City of Tucson, the City of Tampa, and the Texas Health and Human Services Commission. Geographic activity clusters in Arizona, Florida, and Texas. Representative recent opportunities include the City of Tucson's RFP for athletic training services posted May 13, 2026 with response due June 9, 2026, seeking certified athletic trainers to provide injury prevention, treatment, and rehabilitation for fire and police personnel on an as-needed basis with contract term of one year plus four optional one-year renewals; the City of Tampa Fire Rescue Department's ITB for medical aid supplies (antiseptic sprays, bandages, pain relievers, first aid kits, emergency blankets, and similar items) posted April 24, 2026 with a due date of April 9, 2025 and a total department budget of $100,000, including set-aside provisions for Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises; and the Texas Health and Human Services Commission's RFI posted April 3, 2026 seeking vendor information on direct-to-manufacturer prescription fulfillment programs. Given the code's apparent misalignment with actual procurement content, activity under this code warrants verification before resource allocation.